Endometrial Ablation Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Endometrial Ablation Devices Market is segmented by Device Type (Hysteroscopy Devices, Thermal Balloon Ablators, Radiofrequency Endometrial Ablation Devices, Hydrothermal Ablators, Electrical Ablators, and Others) End-User (Ambulatory Surgical Centers, Hospitals, and Clinics), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa and South America). The report offers the value (in USD million) for the above segments.

Endometrial Ablation Devices Market Size

Endometrial Ablation Devices Market Summary
Study Period: 2019-2027
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 5.2 %

Major Players

Endometrial Ablation Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and it's growth?

Endometrial Ablation Devices Market Analysis

The endometrial ablation devices market studied was projected to grow at a CAGR of 5.2% over the forecast period.

During the COVID-19 outbreak, all outpatient treatments were postponed or restricted to reduce the risk of viral transmission, as most chronic therapies were deemed elective. As per the article published in the Springer Journal in September 2022, during the COVID-19 pandemic, the number of treatments for endometriosis patients was reduced, especially during the first lockdown (March 2020 to May 2020). There was a 37% reduction in the endometriosis outpatient department and a 90% reduction in surgical endometriosis. Thus, the decline in endometrial consultations and surgical procedures during COVID-19 significantly impacted market growth during the initial stages of the pandemic. However, owing to the resumption of endometrial surgeries after the relaxation of strict lockdown regulations during the post-pandemic period, the market is expected to grow over the forecast period.

The major factor attributing to the growth of the market is the increase in the prevalence of gynecological disorders in women, like cervical cancer, menorrhagia, abnormal vaginal bleeding, and PCOD, or polycystic ovarian disease. According to the article published in Elsevier in June 2021, overall, 116 million women were affected by polycystic ovarian syndrome across the world. Additionally, in the study published in the HPV Information Center in October 2021, every year, 351,720 women were diagnosed with cervical cancer in Asia. The report also estimated that a population of 1766.41 million women aged 15 years and older were at risk of developing cervical cancer in Asia. Thus, the growing prevalence of various gynecological diseases is expected to drive demand for endometrial ablation devices owing to the effective treatment, thereby boosting market growth over the forecast period. The increasing number of product launches by various key market players in order to meet the growing demand for endometrial ablation devices is also expected to fuel the market's growth during the forecast period. For instance, in November 2021, Hologic, Inc., launched the NovaSure V5 global endometrial ablation (GEA) device at the 50th Global Congress of the American Association of Gynecologic Laparoscopists (AAGL) in the United States.

Thus, the above-mentioned factors, such as an increase in the prevalence of gynecological disorders and frequent product launches by various market players, are expected to contribute to the growth of the market. However, stringent regulatory policies are expected to impede the growth of the market over the forecast period.

Endometrial Ablation Devices Industry Segmentation

As per the scope of the report, endometrial ablation is a procedure that surgically destroys the lining of the uterus. The goal of endometrial ablation is to reduce menstrual flow; in some women, the menstrual flow stops completely. The endometrial ablation devices market is segmented by device type (hysteroscopy devices, thermal balloon ablators, radiofrequency endometrial ablation devices, hydrothermal ablators, electrical ablators, others), end-user (ambulatory surgical centers, hospitals, clinics), and geography (North America, Europe, Asia-Pacific, the Middle East, Africa, and South America). The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Device Type
Hysteroscopy devices
Thermal balloon ablators
Radiofrequency endometrial ablation devices
Hydrothermal ablators
Electrical ablators
Other Device Types
By End-User
Ambulatory Surgical Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Endometrial Ablation Devices Market Trends

This section covers the major market trends shaping the Endometrial Ablation Devices Market according to our research experts:

Radiofrequency Endometrial Ablation Device is Expected to Hold Significant Share in the Market Over The Forecast Period

Radiofrequency ablation devices are used to transmit radio frequency energy and destroy the tissue lining the uterus (the endometrium). These devices ensure a reduced risk of infection. The notable share of radiofrequency endometrial ablation devices is accounted for by factors such as high safety and fast recovery, increasing awareness related to this technique in developing countries, and high preference from several medical practitioners. Apart from the advantages of the devices, the factors driving segment growth are the increasing prevalence of cervical cancer, menorrhagia, and other gynecologic disorders.

According to the NCBI study published in August 2022, in the clinical trial conducted to test the safety and efficacy of the Cerene device, a radiofrequency endometrial ablation device, 91% of the enrolled subjects reported that they had no limitations in the activity of the device, and 85% of the subjects were satisfied with the performance of the device. Thus, the higher safety and efficacy of the radiofrequency ablation system are expected to increase segment growth over the forecast period. Moreover, the growing prevalence of endometrial cancer is expected to boost segment growth. As per the ACS 2022 update, there were more than 600,000 survivors of endometrial cancer in the United States. According to the same source, around 65,950 new cases of cancer of the body of the uterus (uterine body or corpus) are expected to be diagnosed in 2022. Thus, the growing prevalence of endometrial cancer is expected to increase demand for endometrial ablation devices.

Additionally, the increasing number of product approvals is also expected to contribute to the growth of the market. For instance, in September 2021, Gynesonics received approval from the US FDA for their next-generation Sonata System 2.2 radiofrequency ablation of fibroid tumors. This Sonata technology platform integrates a commercial intrauterine ultrasound system with an advanced radiofrequency ablation device to provide incision-free, uterus-preserving treatment. Thus, the high safety and efficiency of the radiofrequency endometrial ablation devices and the approval of the advanced products are expected to contribute to the growth of the studied segment.

Endometrial Ablation Devices Market - Number of Women at Risk for Cervical Cancer ( in Millions), By Region, Asia, 2021

North America is Expected to Hold Significant Share in the Market Over the Forecast Period

North America is expected to hold a significant share of the overall market throughout the forecast period. Escalating cases of gynecological disorders, rising healthcare infrastructure, and the strong establishment of major market players to offer innovative endometrial ablation devices are accountable for promoting the endometrial ablation devices market in this region. According to the NCBI study published in May 2022, endometriosis is a chronic inflammatory pain disorder that affects 6.5 million women in the United States each year. Additionally, the data published by the Canadian Cancer Society in 2022 mentioned that an estimated 1,450 Canadian women will be diagnosed with cervical cancer in 2022. Hence, the growing prevalence of endometritis and gynecological disorders in this region is expected to drive the demand for endometrial ablation devices, thereby contributing to the growth of the market in this region.

Additionally, key market players' strategies, such as acquisitions and mergers, and rising investments support market growth. For instance, in October 2021, Hologic, Inc. acquired Bolder Surgical for approximately USD 160 million. The complementary acquisition of Bolder Surgical added to the Hologic surgical product line, which includes the Novasure endometrial ablation system for the treatment of abnormal uterine bleeding. Also, in February 2022, CooperSurgical agreed to spend USD 875 million on Cook Medical's reproductive health portfolio, which includes fertility, obstetrics, gynecology, and in vitro fertilization medical equipment.

Endometrial Ablation Devices Market - Growth Rate by Region

Endometrial Ablation Devices Industry Overview

The endometrial ablation devices The market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Boston Scientific Corporation, Cooper Surgical, Medtronic, Johnson & Johnson, Olympus Corporation, Richard Wolf GmbH, Minerva Surgical, Inc., AngioDynamics, and Hologic, Inc.

Endometrial Ablation Devices Market Leaders

  1. Cooper Surgical

  2. Medtronic

  3. Olympus Corporation

  4. Boston Scientific Corporation

  5. Johnson & Johnson

*Disclaimer: Major Players sorted in no particular order

Endometrial Ablation Devices Market Concentration

Endometrial Ablation Devices Market News

  • October 2022: Channel MedSystems announced that the first procedures in Europe were performed with the Cerene Cryotherapy device for the treatment of heavy menstrual bleeding. Bergman Clinics in Amsterdam were in charge of these procedures.
  • January 2022: Inovus Medical released HystAR, a new high-fidelity hysteroscopy simulator. The HystARTM is the third hysteroscopy simulator in the Inovus portfolio, joining the extremely successful Bozzini Hysteroscopy line that has been on the market for several years.

Endometrial Ablation Devices Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Number of Various Gynecological Disorders

      2. 4.2.2 Growing Demand for Minimally Invasive Surgical Procedures

    3. 4.3 Market Restraints

      1. 4.3.1 Unfavourable Regulatory Framework

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 5.1 By Device Type

      1. 5.1.1 Hysteroscopy devices

      2. 5.1.2 Thermal balloon ablators

      3. 5.1.3 Radiofrequency endometrial ablation devices

      4. 5.1.4 Hydrothermal ablators

      5. 5.1.5 Electrical ablators

      6. 5.1.6 Other Device Types

    2. 5.2 By End-User

      1. 5.2.1 Ambulatory Surgical Centers

      2. 5.2.2 Hospitals

      3. 5.2.3 Clinics

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 Cooper Surgical

      3. 6.1.3 Medtronic Plc

      4. 6.1.4 Johnson & Johnson

      5. 6.1.5 Olympus Corporation

      6. 6.1.6 Richard Wolf GmbH

      7. 6.1.7 Minerva Surgical, Inc.

      8. 6.1.8 AngioDynamics

      9. 6.1.9 Hologic, Inc.

      10. 6.1.10 AEGEA Medica Inc

      11. 6.1.11 Teoranta

      12. 6.1.12 Veldana Medical SA

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Endometrial Ablation Devices Market Research FAQs

The Endometrial Ablation Devices Market is studied from 2019 - 2027.

The Endometrial Ablation Devices Market is growing at a CAGR of 5.2% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2019-2027.

North America holds highest share in 2021.

Cooper Surgical, Medtronic, Olympus Corporation, Boston Scientific Corporation, Johnson & Johnson are the major companies operating in Endometrial Ablation Devices Market.

Endometrial Ablation Devices Industry Report

Statistics for the 2023 Endometrial Ablation Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Endometrial Ablation Devices analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!